Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Mycobacterium Infections"
Show Display Options
Rank Status Study
1 Recruiting TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Condition: Tuberculosis
Interventions: Drug: rifapentine;   Drug: rifapentine and moxifloxacin;   Drug: control

Indicates status has not been verified in more than two years